• Tue news: 23andMe CEO no longer open to takeover. mRNA vaccines may boost cancer immunotherapy. BMS beats $6.4B lawsuit. CVS Health layoffs and potential breakup. JNJ abandoning proposed 340b plan. See more on our front page

Merck reps get more respect for senior leadership than Amgen or Sanofi

Anonymous

Guest
No matter how bad it is here at least we are getting more respect from our leadership than reps from Amgen or Sanofi!

If you look at those boards you will see how their Senior leadership humiliated them on investor calls.

On the AMgen board, look for the post that says, "Amgen has no rep loyalty, offensive rep comments..."

On the Sanofi board, look for the post titled, "US salesforce ineffective..."


We need to monitor all Merck calls so we can complain if they pull this crap on us!
 

<



No matter how bad it is here at least we are getting more respect from our leadership than reps from Amgen or Sanofi!

If you look at those boards you will see how their Senior leadership humiliated them on investor calls.

On the AMgen board, look for the post that says, "Amgen has no rep loyalty, offensive rep comments..."

On the Sanofi board, look for the post titled, "US salesforce ineffective..."


We need to monitor all Merck calls so we can complain if they pull this crap on us!

And just what do you think you are going to do? Grow up!